ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,000 | +60.0% | 9,257 | +14.4% | 0.00% | – |
| Q4 2020 | $10,000 | -9.1% | 8,093 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -15.4% | 8,093 | -25.6% | 0.00% | – |
| Q2 2020 | $13,000 | -7.1% | 10,880 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | -53.3% | 10,880 | -22.5% | 0.00% | – |
| Q4 2019 | $30,000 | +3.4% | 14,038 | +7.6% | 0.00% | – |
| Q3 2019 | $29,000 | +3.6% | 13,046 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | +40.0% | 13,046 | +104.6% | 0.00% | – |
| Q1 2017 | $20,000 | +53.8% | 6,376 | +30.4% | 0.00% | – |
| Q4 2016 | $13,000 | -31.6% | 4,888 | -5.1% | 0.00% | – |
| Q1 2015 | $19,000 | -45.7% | 5,152 | 0.0% | 0.00% | – |
| Q4 2014 | $35,000 | +16.7% | 5,152 | 0.0% | 0.00% | – |
| Q3 2014 | $30,000 | – | 5,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $25,376,000 | 1.97% |
| SENZAR ASSET MANAGEMENT, LLC | 1,040,681 | $4,017,000 | 0.98% |
| Cormorant Asset Management, LP | 850,000 | $3,281,000 | 0.51% |
| Palo Alto Investors LP | 2,135,739 | $8,244,000 | 0.41% |
| Opus Point Partners Management, LLC | 99,959 | $386,000 | 0.32% |
| Granahan Investment Management | 1,527,837 | $5,897,000 | 0.17% |
| WALL STREET ASSOCIATES | 367,200 | $1,417,000 | 0.13% |
| CAXTON CORP | 21,870 | $84,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 107,392 | $415,000 | 0.07% |
| Joel Isaacson & Co., LLC | 70,660 | $273,000 | 0.07% |